A Clinical Approach for Defining the Threshold between Low and Medium Anti-Cardiolipin Antibody Levels for QUANTA Flash Assays

A Clinical Approach for Defining the Threshold between Low and Medium Anti-Cardiolipin Antibody Levels for QUANTA Flash Assays

The threshold between low and medium antibody levels for anticardiolipin (aCL) and anti-β2 glycoprotein I antibodies (aβ2GPI) for the diagnosis of antiphospholipid syndrome (APS) remains a matter of discussion. Our goal was to create a protocol for determining the low/medium antibody cut-off for aCL...

Full description

Bibliographic Details
Main Authors: Gabriella Lakos, Chelsea Bentow, Michael Mahler
Format: Article
Language:English
Published: MDPI AG 2016-05-01
Series:Antibodies
Subjects:
antiphospholipid syndrome
anticardiolipin antibodies
low/medium antibody threshold
chemiluminescent immunoassay
Online Access:http://www.mdpi.com/2073-4468/5/2/14

Internet

http://www.mdpi.com/2073-4468/5/2/14

Similar Items